New device could catch colon cancers that stool tests miss

NCT ID NCT07623902

Recruiting now Diagnosis Sponsor: Jubaan Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called Gixam to see if it can find precancerous growths or colon cancer in people aged 45-84 who had a negative stool test (FIT). About 1,436 participants will use the Gixam device, take a home stool test, and then get a standard colonoscopy. The goal is to see if Gixam catches cancers that stool tests miss, improving early detection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRC SCREENING MICROBIOME

Contacts and locations

Locations

Blue Ridge Medical Research
RECRUITING

Lynchburg, Virginia, 24502, United States
Comprehensive Gastrointestinal Health, LLC
RECRUITING

Northbrook, Illinois, 60062, United States
Great Lakes Gastroenterology Research, LLC
RECRUITING

Mentor, Ohio, 44060, United States
Orlando Gastroenterology, PA
RECRUITING

Orlando, Florida, 32835, United States
Westchester Putnam Gastro
RECRUITING

Carmel, New York, 10549, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.